These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21373268)
1. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase. Tanigawa T; Watanabe T; Ohkawa F; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T J Clin Biochem Nutr; 2011 Mar; 48(2):149-53. PubMed ID: 21373268 [TBL] [Abstract][Full Text] [Related]
2. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis. Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796 [TBL] [Abstract][Full Text] [Related]
5. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5. Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631 [TBL] [Abstract][Full Text] [Related]
6. Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa. Suetsugu H; Ishihara S; Moriyama N; Kazumori H; Adachi K; Fukuda R; Watanabe M; Kinoshita Y J Lab Clin Med; 2000 Jul; 136(1):50-7. PubMed ID: 10882227 [TBL] [Abstract][Full Text] [Related]
7. Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats. Naito Y; Kuroda M; Mizushima K; Takagi T; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T J Clin Biochem Nutr; 2007 Nov; 41(3):202-10. PubMed ID: 18299717 [TBL] [Abstract][Full Text] [Related]
8. Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model. Kurata S; Nakashima T; Osaki T; Uematsu N; Shibamori M; Sakurai K; Kamiya S J Clin Biochem Nutr; 2015 Jan; 56(1):20-7. PubMed ID: 25834302 [TBL] [Abstract][Full Text] [Related]
9. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells. Joh T; Takezono Y; Oshima T; Sasaki M; Seno K; Yokoyama Y; Ohara H; Nomura T; Alexander JS; Itoh M Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():133-8. PubMed ID: 12925151 [TBL] [Abstract][Full Text] [Related]
10. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Darling RL; Romero JJ; Dial EJ; Akunda JK; Langenbach R; Lichtenberger LM Gastroenterology; 2004 Jul; 127(1):94-104. PubMed ID: 15236176 [TBL] [Abstract][Full Text] [Related]
11. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression. Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Kleine A; Kluge S; Peskar BM Dig Dis Sci; 1993 Aug; 38(8):1441-9. PubMed ID: 8393757 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005 [TBL] [Abstract][Full Text] [Related]
15. Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. Yamamoto T; Isono A; Mishina Y; Ebato T; Shirai T; Nakayama S; Nagasawa K; Abe K; Hattori K; Ishii T; Kuyama Y J Clin Biochem Nutr; 2010 Jul; 47(1):27-31. PubMed ID: 20664727 [TBL] [Abstract][Full Text] [Related]
16. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats. Murakami K; Okajima K; Harada N; Isobe H; Okabe H Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240 [TBL] [Abstract][Full Text] [Related]
17. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Bhang CS; Lee HS; Kim SS; Song HJ; Sung YJ; Kim JI; Chung IS; Sun HS; Park DH; Lee YS Helicobacter; 2002 Feb; 7(1):14-21. PubMed ID: 11886470 [TBL] [Abstract][Full Text] [Related]